Thursday, June 20, 2019 9:32:45 AM
LAHO! Global Stem Cells Group Takes Part in Clinical Trial.
Global’s doctors participate in research exploring the safety and improvement of protocols using adipose-derived stem cells.
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
LAHO! GSCG..Plans Bone Marrow Clinical Trials For Knee Osteoarthritis
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
..The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2015 to 2022 and reach a market value of US$297 billion by 2022. (Stem Cells Market Global Industry Analysis, Size, Share, Growth By 2022
https://cellpro.tech/market/
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
..Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection
..Improvement in Pain: VAS [ Time Frame: 48 weeks ]
≥ 14-millimeter (mm) improvement in Visual Analog Scale (VAS)
..Studies a U.S. FDA-regulated Device Product: Yes
Principal Investigator: Jason Hurd, MD Sanford Orthopedics & Sports Medicine
https://clinicaltrials.gov/ct2/show/NCT03752827.
Global Stem Cells Group a giant in the making, in trials for Adipose stem cells, the largest sector by market value.
LAHO$
Global’s doctors participate in research exploring the safety and improvement of protocols using adipose-derived stem cells.
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
LAHO! GSCG..Plans Bone Marrow Clinical Trials For Knee Osteoarthritis
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
..The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2015 to 2022 and reach a market value of US$297 billion by 2022. (Stem Cells Market Global Industry Analysis, Size, Share, Growth By 2022
https://cellpro.tech/market/
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
..Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection
..Improvement in Pain: VAS [ Time Frame: 48 weeks ]
≥ 14-millimeter (mm) improvement in Visual Analog Scale (VAS)
..Studies a U.S. FDA-regulated Device Product: Yes
Principal Investigator: Jason Hurd, MD Sanford Orthopedics & Sports Medicine
https://clinicaltrials.gov/ct2/show/NCT03752827.
Global Stem Cells Group a giant in the making, in trials for Adipose stem cells, the largest sector by market value.
LAHO$
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
